Pathological evaluation of sentinel lymph nodes for breast cancer

Asian Journal of Surgery

Volumn 27, Issue 4, 2004, Pages 256-261

  Moriya, Takuya ^a   Usami, Shin ^a   Tada, Hiroshi ^a   Kasajima, Atsuko ^a   Ishida, Kazuyuki ^a   Kariya, Yoshiyuki ^a   Ohuchi, Noriaki ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER SIZE; CONFERENCE PAPER; CONSULTATION; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; SENTINEL LYMPH NODE BIOPSY; TISSUE FIXATION; TISSUE SECTION;

EID: 7044285910     PISSN: 10159584     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1015-9584(09)60047-6     Document Type: Conference Paper

References (46)

1. The Research Group of Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1997. Estimates based on data from 12 population-based cancer registries. Jpn J Clin Oncol 2002;32:318-22.
2. Silverberg SG, Chitale AR. Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast. Cancer 1973;32:830-7.
3. th issue. Osaka Prefecture, Japan: Osaka Cancer Registry, 2002. [In Japanese]
4. Cserni G, Amendoeira I, Apostolikas N, et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003; 39:1654-67.
5. Pikren JW. Significance of occult metastases. Cancer 1961;14:1266-71.
6. nd edition. New York: Churchill-Livingstone, 1989:375-430.
7. Diaz LK, Hunt K, Ames F, et al. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 2003;27: 385-9.
8. Weaver DL. Sentinel lymph nodes and breast carcinoma. Which micrometastases are clinically significant? Am J Surg Pathol 2003;27: 842-5.
9. th edition. New York: Springer, 2002:223-40.
10. Schwartz GF, Giuliano AE, Veronesi U, for the Consensus Conference Committee. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19-22, 2001, Philadelphia, Pennsylvania. Hum Pathol 2002;33: 579-89.
11. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
12. Strattmann SL, McCarthy TM, Kuhn J. Radiation safety with breast sentinel node biopsy. Am J Surg 1999;178:454-7.
13. Viale G, Bosari S, Mazzarol G, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999;85:2433-8.
14. Canavese G, Gipponi M, Catturich A, et al. Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: a combined approach with vital blue dye lymphatic mapping and radioguided surgery. Semin Surg Oncol 1998; 15:272-7.
15. Schneebaum S, Standler J, Cohen M, et al. Gamma probe-guided sentinel node biopsy - optimal timing for injection. Eur J Surg Oncol 1998:24:515-9.
16. Koller M, Barsuk D, Zippel D, et al. Sentinel lymph node involvement - a predictor for axillary node status with breast cancer - has the time come? Eur J Surg Oncol 1998;24:166-8.
17. Imoto S, Fukukita H, Murakami K, et al. Pilot study on sentinel node biopsy in breast cancer. J Surg Oncol 2000;73:130-3.
18. Noguchi M, Tsugawa K, Miwa K, et al. Sentinel lymph node biopsy in breast cancer using blue dye with or without isotope localization. Breast Cancer 2000;7:287-96.
19. Motomura K, Inaji H, Komoike Y, et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 2000;87:597-601.
20. Weiser MR, Montgomery LL, Susnik B, et al. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast carcinoma worthwhile? Ann Surg Oncol 2000;7:651-5.
21. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368-73.
22. Moriya T, Manabe T, Irei I, et al. Significance of imprint/scrape cytology in intraoperative consultation of breast diseases. Pathol Clin Med 1994;12:719-23. [In Japanese]
23. Rubio IT, Korourian S, Cowan C, et al. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 1998;5:689-94.
24. Ratanawichitrasin A, Biscotti CV, Levy L, et al. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br J Surg 1999;86:1346-8.
25. Henry-Tillman RS, Korourian S, Rubio IT, et al. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann Surg Oncol 2002;9:333-9.
26. Karamlou T, Johnson NM, Chan B, et al. Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer. Am J Surg 2003;185:425-8.
27. Dowlatshahi K, Fan M, Bloom KJ, et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study. Cancer 1999;86:990-6.
28. Turner RR, Ollila DW, Stern S, et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999;23:263-7.
29. Nahrig J, Richter T, Kowolik J, et al. Comparison of different histopathological methods for the examination of sentinel lymph nodes in breast cancer. Anticancer Res 2000;20:2209-12.
30. Torrenga H, Rahusen FD, Meijer S, et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001;54:550-2.
31. Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85: 1098-103.
32. Noguchi M, Bando E, Tsugawa K, et al. Staging efficacy of breast cancer with sentinel lymphadenectomy. Breast Cancer Res Treat 1999; 57:221-9.
33. Pendas S, Dauway E, Cox CE, et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 1999;65:500-5.
34. Kowolik JH, Kuhn W, Nahrig J, et al. Detection of micrometastases in sentinel lymph nodes of the breast applying monoclonal antibodies AE1/AE3 to pancytokeratins. Oncol Rep 2000;7:745-9.
35. Mann BG, Buchanan M, Collins PJ, et al. High incidence of micrometastases in breast cancer sentinel nodes. Aust NZ J Surg 2000;70: 786-90.
36. Wong SL, Chao C, Edwards MJ, et al, for the University of Louisville Breast Cancer Study Group. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182: 330-4.
37. Salem AA, Douglas-Jones AG, Sweetland HM, et al. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. I. Protocol of rapid immuno-staining of touch imprints. Eur J Surg Oncol 2003;29:25-8.
38. Freneaux P, Nos C, Vincent-Salomon A, et al. Histological detection of minimal metastatic involvement in axillary sentinel nodes. A rational basis for a sensitive methodology usable in daily practice. Mod Pathol 2002;15:641-6.
39. Carter BA, Jensen RA, Simpson JF, et al. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 2000;113:259-65.
40. Page DL, Carter BA. Sentinel lymph nodes, breast cancer, and pseudometastases. Breast Dis 2002;12:362-3.
41. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574-81.
42. Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229:536-41.
43. Liu GJ, Fan ZM, Tang Q, et al. Lymphatic mapping and sentinel lymph node biopsy in the patients with breast cancer. Clin J Cancer Res 2000;12:293-5.
44. Turner RR, Ollila DW, Krasne DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-6.
45. Millis RR, Springall R, Lee AH, et al. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer 2002;86:396-401.
46. Lagios MD. Clinical significance of immunohistochemically detectable epithelial cells in sentinel lymph node and bone marrow in breast cancer. J Surg Oncol 2003;83:1-4.